Organic compounds
    2.
    发明授权
    Organic compounds 有权
    有机化合物

    公开(公告)号:US08497286B2

    公开(公告)日:2013-07-30

    申请号:US13616081

    申请日:2012-09-14

    IPC分类号: A61K31/444 C07D211/32

    CPC分类号: C07D401/12

    摘要: The present invention relates to a compound of the formula I wherein R1, R2, R3, R4 and R5 are as defined in the specification, for use in the diagnostic and therapeutic treatment of a warm-blooded animal, especially for the treatment of a disease (=disorder) that depends on activity of renin; the use of a compound of that class for the preparation of a pharmaceutical formulation for the treatment of a disease that depends on activity of renin; the use of a compound of that class in the treatment of a disease that depends on activity of renin; pharmaceutical formulations a compound of that class; a method of treatment comprising administering a compound of that class and a method for its manufacture.

    摘要翻译: 本发明涉及式I化合物,其中R1,R2,R3,R4和R5如说明书中所定义,用于诊断和治疗温血动物,特别是用于治疗疾病 (=无效),依赖于肾素的活性; 使用该类化合物制备用于治疗依赖于肾素活性的疾病的药物制剂; 使用该类化合物治疗依赖于肾素活性的疾病; 药物制剂是该类化合物; 一种治疗方法,包括施用该类化合物及其制备方法。

    Substituted Piperdines as Renin Inhibitors
    9.
    发明申请
    Substituted Piperdines as Renin Inhibitors 审中-公开
    取代喋呤作为肾素抑制剂

    公开(公告)号:US20090137566A1

    公开(公告)日:2009-05-28

    申请号:US11914869

    申请日:2006-05-24

    摘要: The invention relates to substituted 3,4- or higher substituted piperididine compounds, the use thereof for the preparation of a pharmaceutical formulation for the treatment of a disease that depends on activity of renin; the use of a compound of that class in the treatment of a disease that depends on activity of renin; these compounds for use in the diagnostic and therapeutic treatment of a warm-blooded animal, especially for the treatment of a disease (=disorder) that depends on activity of renin; pharmaceutical formulations or products comprising said compounds, and/or a method of treatment comprising administering said compounds, a method for the manufacture of said compounds, as well as novel intermediates, starting materials and/or partial steps for their synthesis. The compounds preferably have the formula I, wherein the moieties R1, R2, R11 and W are as defined in the specification.

    摘要翻译: 本发明涉及取代的3,4-或更高级取代的哌啶化合物,其用于制备用于治疗依赖于肾素活性的疾病的药物制剂; 使用该类化合物治疗依赖于肾素活性的疾病; 这些化合物用于诊断和治疗温血动物,特别是用于治疗依赖于肾素活性的疾病(=病症); 药物制剂或包含所述化合物的产品,和/或包括给药所述化合物的方法,制备所述化合物的方法,以及新型中间体,起始材料和/或其合成的部分步骤。 化合物优选具有式I,其中部分R1,R2,R11和W如说明书中所定义。

    ORGANIC COMPOUNDS
    10.
    发明申请
    ORGANIC COMPOUNDS 有权
    有机化合物

    公开(公告)号:US20080319018A1

    公开(公告)日:2008-12-25

    申请号:US12146073

    申请日:2008-06-25

    CPC分类号: C07D401/12

    摘要: The present invention relates to a compound of the formula I wherein R1, R2, R3, R4 and R5 are as defined in the specification, for use in the diagnostic and therapeutic treatment of a warm-blooded animal, especially for the treatment of a disease (=disorder) that depends on activity of renin; the use of a compound of that class for the preparation of a pharmaceutical formulation for the treatment of a disease that depends on activity of renin; the use of a compound of that class in the treatment of a disease that depends on activity of renin; pharmaceutical formulations a compound of that class; a method of treatment comprising administering a compound of that class and a method for its manufacture.

    摘要翻译: 本发明涉及式I化合物,其中R1,R2,R3,R4和R5如说明书中所定义,用于诊断和治疗温血动物,特别是用于治疗疾病 (=无效),依赖于肾素的活性; 使用该类化合物制备用于治疗依赖于肾素活性的疾病的药物制剂; 使用该类化合物治疗依赖于肾素活性的疾病; 药物制剂是该类化合物; 一种治疗方法,包括施用该类化合物及其制备方法。